ME

Metabolic Nordic AB

Develops digital solutions for the health sector with a focus on medical weight loss.

MBOLIC | ST

Overview

Corporate Details

ISIN(s):
SE0015797352 (+3 more)
LEI:
9845002D5054CA4BDF44
Country:
Sweden
Address:
Djäknegatan 9, 211 35 MALMÖ

Description

Metabolic Nordic AB, formerly known as Twiik AB, is an innovation company that develops digital solutions for the health and wellness sector. The company's legacy operations include an online marketplace and coaching platform for personal trainers and gyms to digitize their services, offering digital training programs, bootcamps, and corporate wellness challenges. Following its rebranding in 2024, the company has shifted its strategic focus to medical weight loss. This new direction is centered on online services, such as Dr. Vitos, which provides digital solutions for weight management and improved health.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Metabolic Nordic AB filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Metabolic Nordic AB

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Metabolic Nordic AB via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Cardiol Therapeutics Inc. Logo
Clinical-stage company developing anti-inflammatory and anti-fibrotic heart therapies.
United States of America
CRDL
CAREGEN CO.,LTD. Logo
Develops biomimetic peptides and growth factors for aesthetic and medical solutions.
South Korea
214370
Caribou Biosciences, Inc. Logo
Clinical-stage biopharma developing genome-edited allogeneic cell therapies.
United States of America
CRBU
Carisma Therapeutics Inc. Logo
A clinical-stage biotech developing engineered macrophage-based therapeutics for cancer.
United States of America
CARM
Carna Biosciences, Inc. Logo
Clinical-stage biopharma developing small molecule kinase inhibitors.
Japan
4572
Cartesian Therapeutics, Inc. Logo
A clinical-stage company developing mRNA-engineered cell therapies for autoimmune diseases.
United States of America
RNAC
CASI Pharmaceuticals, Inc. Logo
Biopharmaceutical firm developing therapeutics for organ transplant and autoimmune diseases.
United States of America
CASI
CATALYST PHARMACEUTICALS, INC. Logo
Biopharmaceutical company commercializing drugs for rare neurological and autoimmune diseases.
United States of America
CPRX
cbdMD, Inc. Logo
Producer and distributor of health and wellness CBD products from U.S.-grown hemp.
United States of America
YCBD
CDT Equity Inc. Logo
A clinical-stage biopharmaceutical firm advancing assets for unmet medical needs.
United States of America
CDT

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.